TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-253 Cr | ₹319 Cr | ₹30 Cr | ₹-175 Cr | ₹-95 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹-253 Cr |
Mar2024 | ₹319 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹-175 Cr |
Mar2021 | ₹-95 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹-253 Cr | Negative | |
Mar2024 | ₹319 Cr | 955.47 | |
Mar2023 | ₹30 Cr | Positive | |
Mar2022 | ₹-175 Cr | Negative | |
Mar2021 | ₹-95 Cr | - |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹122,269.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
MANKIND PHARMA | ₹108,482.0 Cr | 3% | 7.8% | 27.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -4.1% |
7.3% |
14.3% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses